Clinical Trials Logo

Acute Ankle Sprain clinical trials

View clinical trials related to Acute Ankle Sprain.

Filter by:
  • None
  • Page 1

NCT ID: NCT01874626 Active, not recruiting - Acute Ankle Sprain Clinical Trials

Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain

Start date: July 2013
Phase: Phase 3
Study type: Interventional

This is a randomized, multi-center, double-blind, placebo-controlled, multi-dose, parallel-group study. Approximately 300 subjects (150 per group) 16 years of age and older with a current (within 24 hours from Visit 1) Grade I or II ankle sprain, and who meet all eligibility criteria, will be randomized into the study and will receive either the active treatment (SST-0225 ibuprofen cream), or matching placebo. Subjects will apply an amount equivalent to a 4 inch line of investigational product to the affected ankle approximately every 4-6 hours. At Visit 1 two doses will be applied at the site. All subsequent doses of the investigational product will be applied every 4 to 6 hours with a total of 4 doses in a 24 hour period. Duration of treatment with the investigational product is 7 days.

NCT ID: NCT01586390 Completed - Ankle Injuries Clinical Trials

Functional Treatment for Acute Ankle Sprains: Softcast Wrap Versus MOKcast

Start date: June 2009
Phase: Phase 2
Study type: Interventional

In this study we compare two treatment options for ankle sprains. 100 patients were randomised between a flexible cast treatment and a removable and adjustable brace made out of the same materials. Follow-up was 4 months. Primary outcome were functional scores. Secondary outcome measures were patient satisfaction scores with treatment as well as treatment result.

NCT ID: NCT01272934 Completed - Acute Ankle Sprain Clinical Trials

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain

Start date: January 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.